TABLE 1.
Control | Rapamycin | |
---|---|---|
Body weight (g) | 303.6 ± 3.68 | 226.3 ± 4.34*** |
Weight gain (g) | 91.4 ± 3.57 | 12.8 ± 3.87*** |
Food intake (g) | 256.4 ± 6.53 | 217.7 ± 8.53** |
Food efficiency (body weight gain/food intake) | 0.117 ± 0.004 | 0.019 ± 0.006*** |
Glucose (mmol/l) | 8.5 ± 0.33 | 13.3 ± 2.53* |
Insulin (pmol/l) | 351.5 ± 58.7 | 1,265.1 ± 395.1* |
Glucagon (ng/l) | 127.25 ± 10.65 | 130.47 ± 14.33 |
Triglycerides (mmol/l) | 0.644 ± 0.050 | 0.848 ± 0.060* |
NEFAs (mmol/l) | 0.115 ± 0.020 | 0.190 ± 0.040* |
Glycerol (mg/dl) | 1.025 ± 0.084 | 1.177 ± 0.107 |
Lactate (mmol/l) | 0.904 ± 0.050 | 0.852 ± 0.039 |
Adiponectin (μg/ml) | 11.89 ± 1.53 | 12.11 ± 0.83 |
Leptin (ng/ml) | 9.48 ± 1.86 | 4.94 ± 1.51* |
Data are average ± SE (n = 12 control, n = 10 for rapamycin). Refed plasma data are average ± SE (n = 6–12 for control, n = 6–10 for rapamycin).
*P ≤ 0.05,
**P ≤ 0.01,
***P ≤ 0.001 vs. control. NEFAs, nonesterified fatty acids.